signs of prostate cancer
signs of prostate cancer questions and answers
All the information you need about signs of prostate cancer Check out CheckTheProstate.com For all your Prostate Cancer Questions & Answers
Q: I have already spent like five thousand on therapy and etc. it has not helped out any with the prostate cancer?
today is his worse day ever not sure what too do i cant find myself to put him to sleep but i know he is suffering , they put him on this medc. five days ago too see if it would help but it has shown no signs of helping , i guess i will be taking him to see the vet in the morning, but i watched him pee ealier and thought i seen a trace of blood in it I dont believe that is good
A: you may want to consider a vet that can provide alternative medical treatment. Additionally, you many want to find a certified Reiki practitioner in your area who deals with animals. Animals respond well to Reiki. I volunteered my services at the SPCA for 6 months and did Reiki on the cats and kittens. The animals love the Reiki energy and become calm and less depressed, and they do heal medically in many instances. Go to google and type in William Lee Rand. He is an international Reiki teacher. He also lists different areas where there are certified Reiki practitioners who deal with animals. His website also hosts his quarterly journal that discusses metaphysical healing.
Q: How low will the risk of testicular cancer drop from masturbation?
Right now I'm 16 and not sexually active. I've yet to masturbate as I've found other ways to replace my time. Now I want to stay healthy, and what not and I'm pretty sure getting testicular or prostate cancer is kinda going the other way.
So my question is by masturbating does it only lower the chance by a low margin? Or is it big enough to where if you don't your just signing your own death warrant?
A: Other factors come into play, but masturbation (and later sex) can reduce the incidents of testicular and prostate cancer
Q: what r the cancers men can get in their se xual organs except prostate cancers?
Especially the one of the pe nis skin what r its signs?
A: Carcinoma of the penis
Testicular cancer
Urethral cancer
Anal cancer
NB Breast cancer is also common in men
Q: so gentleman of the scottish section,can i ask?
is anyone doing the MOVEMBER charity thing.ie growing a moustache in the month of november.prostate cancer charity.im signed up and hoping to raise some cashfae workmates and pals.its a cracking idea and it aint running a marathon.thank god
so do i erra.lol
com,if im going to look like a guy out of a 70s porno,i wish i had grown one years ago
A: You've talked me into it. Perhaps we could all post photographs on the 30th of the monstrosities we've cultivated.
Q: please explain the problem of the following article, please!?
A diagnosis of prostate cancer is scary enough. But just as scary is that nobody can tell a man the best way to treat it.
This month, the Agency for Healthcare Research and Quality issued a sweeping review of prostate cancer treatments, including surgical removal, radiation, hormone therapy and so-called watchful waiting, which involves careful monitoring but no active treatment until the cancer shows signs of growing.
Because none of these treatments emerged as superior, the agency came to the troubling conclusion that it could not recommend one over the others.
“Having been involved in this area for a long time, it was not shocking, but it is disappointing,” said Dr. Timothy J. Wilt, lead researcher on the report, from the Minneapolis Veterans Affairs Center for Chronic Disease Outcomes Research. “Information is really lacking to determine whether over all one treatment is more effective and preferred.”
Prostate cancer is the single most common cancer in the United States and the second most lethal among men after lung cancer. In 2008, the American Cancer Society estimates, 186,320 men will learn that they have it and 28,660 will die from it. The estimates for breast cancer are 182,460 and 40,480.
Prostate cancer is often diagnosed with a blood test that looks for prostate-specific antigen, P.S.A. There is widespread consensus that the test casts too wide a net, resulting in overdiagnosis and overtreatment. And the treatment can be devastating, leaving men impotent, incontinent or both.
The reasons behind the lack of data on prostate cancer are complex. A lack of financing and advocacy have roles. But so does the fact that prostate tumors grow slowly and can take 10 or more years to turn deadly. Not only does that make the disease particularly expensive and time consuming to study, but it is also a built-in disincentive for the drug industry, which typically has patent protection from 7 to 20 years.
A bigger obstacle to finding answers may be the patients, who have long been reluctant to participate in clinical trials, and their doctors, who tend to scorn such trials because they are already convinced that their chosen treatment is the best option.
One major clinical trial called Spirit, for Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial, would have compared surgical removal with brachytherapy, which involves implanting radioactive seeds. Just 56 of the 1,980 needed patients enrolled, and the trial was called off in 2004.
“Men don’t go into the clinical trials,” said Dr. Daniel P. Petrylak, associate professor of medicine and director of the genitourinary oncology program at the Columbia University Medical Center. “That’s the whole problem. Patients ask me all the time, ‘What is the best treatment?’ And I can’t give them an evidence-based approach for that, because we don’t have the data.”
Prostate doctors and patient advocates often compare their cause with that of the other leading sex-specific cancer: one of the largest prostate cancer support groups is called Us Too, a play on the Y-ME National Breast Cancer Organization. The dismal state of prostate cancer research and advocacy pales in comparison to the campaign against breast cancer.
“We’re at least a decade behind where breast cancer awareness is,” Thomas Kirk, president of Us Too, said. “We need to catch up. The lessons learned by breast cancer are the ones we’re trying to apply to prostate cancer.”
Prostate cancer groups have tried to replicate the success of the pink ribbon campaign with their own blue ribbon, but it has yet to gain widespread acceptance. A group advocating the development of imaging technology for prostate screening created a mascot, Prosty the Spokesgland, complete with a theme song, to the tune of “Frosty the Snowman.” Not surprisingly, it has not caught on, either.
Government spending for prostate cancer lags, too. In 2007, the National Cancer Institute spent an estimated $551.1 million on breast cancer research and $305.6 million on prostate cancer. For 2008, the Defense Department, which has a history of supporting health research, has allocated $138 million for breast cancer and $80 million for prostate cancer.
Prostate cancer researchers say the real problem is not so much financing as enlisting doctors and patients on board for clinical trials.
By 2010, men should have some answers from Pivot, the Prostate Cancer Intervention Versus Observation Trial, which is comparing surgical removal with watchful waiting. Results of studies looking at P.S.A. screening as well as the preventive benefits of the supplements vitamin E and selenium are also expected in a few years
A: the problem is finding the home-run marketing campaign
money
finding men who are willing to be in a proper study--maybe they would do it if they were paid?
Q: State what the problem you are fixing in the main body of the following article, please!?
A diagnosis of prostate cancer is scary enough. But just as scary is that nobody can tell a man the best way to treat it.
This month, the Agency for Healthcare Research and Quality issued a sweeping review of prostate cancer treatments, including surgical removal, radiation, hormone therapy and so-called watchful waiting, which involves careful monitoring but no active treatment until the cancer shows signs of growing.
Because none of these treatments emerged as superior, the agency came to the troubling conclusion that it could not recommend one over the others.
“Having been involved in this area for a long time, it was not shocking, but it is disappointing,” said Dr. Timothy J. Wilt, lead researcher on the report, from the Minneapolis Veterans Affairs Center for Chronic Disease Outcomes Research. “Information is really lacking to determine whether over all one treatment is more effective and preferred.”
Prostate cancer is the single most common cancer in the United States and the second most lethal among men after lung cancer. In 2008, the American Cancer Society estimates, 186,320 men will learn that they have it and 28,660 will die from it. The estimates for breast cancer are 182,460 and 40,480.
Prostate cancer is often diagnosed with a blood test that looks for prostate-specific antigen, P.S.A. There is widespread consensus that the test casts too wide a net, resulting in overdiagnosis and overtreatment. And the treatment can be devastating, leaving men impotent, incontinent or both.
The reasons behind the lack of data on prostate cancer are complex. A lack of financing and advocacy have roles. But so does the fact that prostate tumors grow slowly and can take 10 or more years to turn deadly. Not only does that make the disease particularly expensive and time consuming to study, but it is also a built-in disincentive for the drug industry, which typically has patent protection from 7 to 20 years.
A bigger obstacle to finding answers may be the patients, who have long been reluctant to participate in clinical trials, and their doctors, who tend to scorn such trials because they are already convinced that their chosen treatment is the best option.
One major clinical trial called Spirit, for Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial, would have compared surgical removal with brachytherapy, which involves implanting radioactive seeds. Just 56 of the 1,980 needed patients enrolled, and the trial was called off in 2004.
“Men don’t go into the clinical trials,” said Dr. Daniel P. Petrylak, associate professor of medicine and director of the genitourinary oncology program at the Columbia University Medical Center. “That’s the whole problem. Patients ask me all the time, ‘What is the best treatment?’ And I can’t give them an evidence-based approach for that, because we don’t have the data.”
Prostate doctors and patient advocates often compare their cause with that of the other leading sex-specific cancer: one of the largest prostate cancer support groups is called Us Too, a play on the Y-ME National Breast Cancer Organization. The dismal state of prostate cancer research and advocacy pales in comparison to the campaign against breast cancer.
“We’re at least a decade behind where breast cancer awareness is,” Thomas Kirk, president of Us Too, said. “We need to catch up. The lessons learned by breast cancer are the ones we’re trying to apply to prostate cancer.”
Prostate cancer groups have tried to replicate the success of the pink ribbon campaign with their own blue ribbon, but it has yet to gain widespread acceptance. A group advocating the development of imaging technology for prostate screening created a mascot, Prosty the Spokesgland, complete with a theme song, to the tune of “Frosty the Snowman.” Not surprisingly, it has not caught on, either.
Government spending for prostate cancer lags, too. In 2007, the National Cancer Institute spent an estimated $551.1 million on breast cancer research and $305.6 million on prostate cancer. For 2008, the Defense Department, which has a history of supporting health research, has allocated $138 million for breast cancer and $80 million for prostate cancer.
Prostate cancer researchers say the real problem is not so much financing as enlisting doctors and patients on board for clinical trials.
By 2010, men should have some answers from Pivot, the Prostate Cancer Intervention Versus Observation Trial, which is comparing surgical removal with watchful waiting. Results of studies looking at P.S.A. screening as well as the preventive benefits of the supplements vitamin E and selenium are also expected in a few years.
“This is the state of prostate cancer,” Mr. Kirk of Us Too said. “There aren’t any clear answers.”
A: Homework - try the Homework forum.
Q: please explain the problem about the following article, please!?
A diagnosis of prostate cancer is scary enough. But just as scary is that nobody can tell a man the best way to treat it.
This month, the Agency for Healthcare Research and Quality issued a sweeping review of prostate cancer treatments, including surgical removal, radiation, hormone therapy and so-called watchful waiting, which involves careful monitoring but no active treatment until the cancer shows signs of growing.
Because none of these treatments emerged as superior, the agency came to the troubling conclusion that it could not recommend one over the others.
“Having been involved in this area for a long time, it was not shocking, but it is disappointing,” said Dr. Timothy J. Wilt, lead researcher on the report, from the Minneapolis Veterans Affairs Center for Chronic Disease Outcomes Research. “Information is really lacking to determine whether over all one treatment is more effective and preferred.”
Prostate cancer is the single most common cancer in the United States and the second most lethal among men after lung cancer. In 2008, the American Cancer Society estimates, 186,320 men will learn that they have it and 28,660 will die from it. The estimates for breast cancer are 182,460 and 40,480.
Prostate cancer is often diagnosed with a blood test that looks for prostate-specific antigen, P.S.A. There is widespread consensus that the test casts too wide a net, resulting in overdiagnosis and overtreatment. And the treatment can be devastating, leaving men impotent, incontinent or both.
The reasons behind the lack of data on prostate cancer are complex. A lack of financing and advocacy have roles. But so does the fact that prostate tumors grow slowly and can take 10 or more years to turn deadly. Not only does that make the disease particularly expensive and time consuming to study, but it is also a built-in disincentive for the drug industry, which typically has patent protection from 7 to 20 years.
A bigger obstacle to finding answers may be the patients, who have long been reluctant to participate in clinical trials, and their doctors, who tend to scorn such trials because they are already convinced that their chosen treatment is the best option.
One major clinical trial called Spirit, for Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial, would have compared surgical removal with brachytherapy, which involves implanting radioactive seeds. Just 56 of the 1,980 needed patients enrolled, and the trial was called off in 2004.
“Men don’t go into the clinical trials,” said Dr. Daniel P. Petrylak, associate professor of medicine and director of the genitourinary oncology program at the Columbia University Medical Center. “That’s the whole problem. Patients ask me all the time, ‘What is the best treatment?’ And I can’t give them an evidence-based approach for that, because we don’t have the data.”
Prostate doctors and patient advocates often compare their cause with that of the other leading sex-specific cancer: one of the largest prostate cancer support groups is called Us Too, a play on the Y-ME National Breast Cancer Organization. The dismal state of prostate cancer research and advocacy pales in comparison to the campaign against breast cancer.
“We’re at least a decade behind where breast cancer awareness is,” Thomas Kirk, president of Us Too, said. “We need to catch up. The lessons learned by breast cancer are the ones we’re trying to apply to prostate cancer.”
Prostate cancer groups have tried to replicate the success of the pink ribbon campaign with their own blue ribbon, but it has yet to gain widespread acceptance. A group advocating the development of imaging technology for prostate screening created a mascot, Prosty the Spokesgland, complete with a theme song, to the tune of “Frosty the Snowman.” Not surprisingly, it has not caught on, either.
Government spending for prostate cancer lags, too. In 2007, the National Cancer Institute spent an estimated $551.1 million on breast cancer research and $305.6 million on prostate cancer. For 2008, the Defense Department, which has a history of supporting health research, has allocated $138 million for breast cancer and $80 million for prostate cancer.
Prostate cancer researchers say the real problem is not so much financing as enlisting doctors and patients on board for clinical trials.
By 2010, men should have some answers from Pivot, the Prostate Cancer Intervention Versus Observation Trial, which is comparing surgical removal with watchful waiting. Results of studies looking at P.S.A. screening as well as the preventive benefits of the supplements vitamin E and selenium are also expected in a few years
A: This article puzzles me. I was diagnosed with prostate cancer last fall, and I had all kinds of options.
As for the PSA test casting a wide net, the doctors all admit that a high PSA test doesn't represent cancer, and to the best of my knowledge, no one undergoes cancer treatment based on one PSA test; the tip-off for a closer look is called PSA acceleration, or a rapid change in the PSA.
My PSA jumped from 1.5 to a 2.3 in one year (I'm 55 and had an otherwise healthy prostate). My Dr scheduled a retest a few month down the road. When that test came back a tad higher, that triggered a reference to a urologist who did a biopsy, a pretty easy procedure. The biopsy contained cancer cells - pretty easy diagnosis.
For treatment options, I sought out 2 surgeons, a local one and one at John Hopkins. There is a lot of data out there, and I believe I was given enough information to make an informed decision (I'm an engineer by training). The choice was mine, and I elected to use the DiVinci robot. The survival rates, as well as recovery rates for other treatments are a matter of record.
While at John Hopkins, I was asked to partake in a study already underway to determine a better marker than a PSA - I agreed.
As for the holistic treatment, I have taken a supplement that contains 50 mcg of selenium and 400 IU of Vit E for probably 30 years or more. I also take Ginko (120 mg x2daily, and had taken Saw Palmetto) I sauna frequently, but have been sedentary of late.
Q: jut one paragram to explain the main idea and prbolem about this article, please!?
A diagnosis of prostate cancer is scary enough. But just as scary is that nobody can tell a man the best way to treat it.
This month, the Agency for Healthcare Research and Quality issued a sweeping review of prostate cancer treatments, including surgical removal, radiation, hormone therapy and so-called watchful waiting, which involves careful monitoring but no active treatment until the cancer shows signs of growing.
Because none of these treatments emerged as superior, the agency came to the troubling conclusion that it could not recommend one over the others.
“Having been involved in this area for a long time, it was not shocking, but it is disappointing,” said Dr. Timothy J. Wilt, lead researcher on the report, from the Minneapolis Veterans Affairs Center for Chronic Disease Outcomes Research. “Information is really lacking to determine whether over all one treatment is more effective and preferred.”
Prostate cancer is the single most common cancer in the United States and the second most lethal among men after lung cancer. In 2008, the American Cancer Society estimates, 186,320 men will learn that they have it and 28,660 will die from it. The estimates for breast cancer are 182,460 and 40,480.
Prostate cancer is often diagnosed with a blood test that looks for prostate-specific antigen, P.S.A. There is widespread consensus that the test casts too wide a net, resulting in overdiagnosis and overtreatment. And the treatment can be devastating, leaving men impotent, incontinent or both.
The reasons behind the lack of data on prostate cancer are complex. A lack of financing and advocacy have roles. But so does the fact that prostate tumors grow slowly and can take 10 or more years to turn deadly. Not only does that make the disease particularly expensive and time consuming to study, but it is also a built-in disincentive for the drug industry, which typically has patent protection from 7 to 20 years.
A bigger obstacle to finding answers may be the patients, who have long been reluctant to participate in clinical trials, and their doctors, who tend to scorn such trials because they are already convinced that their chosen treatment is the best option.
One major clinical trial called Spirit, for Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial, would have compared surgical removal with brachytherapy, which involves implanting radioactive seeds. Just 56 of the 1,980 needed patients enrolled, and the trial was called off in 2004.
“Men don’t go into the clinical trials,” said Dr. Daniel P. Petrylak, associate professor of medicine and director of the genitourinary oncology program at the Columbia University Medical Center. “That’s the whole problem. Patients ask me all the time, ‘What is the best treatment?’ And I can’t give them an evidence-based approach for that, because we don’t have the data.”
Prostate doctors and patient advocates often compare their cause with that of the other leading sex-specific cancer: one of the largest prostate cancer support groups is called Us Too, a play on the Y-ME National Breast Cancer Organization. The dismal state of prostate cancer research and advocacy pales in comparison to the campaign against breast cancer.
“We’re at least a decade behind where breast cancer awareness is,” Thomas Kirk, president of Us Too, said. “We need to catch up. The lessons learned by breast cancer are the ones we’re trying to apply to prostate cancer.”
Prostate cancer groups have tried to replicate the success of the pink ribbon campaign with their own blue ribbon, but it has yet to gain widespread acceptance. A group advocating the development of imaging technology for prostate screening created a mascot, Prosty the Spokesgland, complete with a theme song, to the tune of “Frosty the Snowman.” Not surprisingly, it has not caught on, either.
Government spending for prostate cancer lags, too. In 2007, the National Cancer Institute spent an estimated $551.1 million on breast cancer research and $305.6 million on prostate cancer. For 2008, the Defense Department, which has a history of supporting health research, has allocated $138 million for breast cancer and $80 million for prostate cancer.
Prostate cancer researchers say the real problem is not so much financing as enlisting doctors and patients on board for clinical trials.
By 2010, men should have some answers from Pivot, the Prostate Cancer Intervention Versus Observation Trial, which is comparing surgical removal with watchful waiting. Results of studies looking at P.S.A. screening as well as the preventive benefits of the supplements vitamin E and selenium are also expected in a few years
A: In just one paragraph, the main idea is that men should learn all they can about the prostate gland, what its function is, signs of prostate problems and to have your doctor perform the necessary tests to rule out any problems or suppected problems.
Q: question help, please!?
write it in your own word of the following paragraph?
This month, the Agency for Healthcare Research and Quality issued a sweeping review of prostate cancer treatments, including surgical removal, radiation, hormone therapy and so-called watchful waiting, which involves careful monitoring but no active treatment until the cancer shows signs of growing.
A: The treatment for prostate cancer is constantly under review by The Agency for Healthcare research and quality. They reviewed treatments such as surgical removal and a number of therapies, including hormone injections and radiation. The Agency also reviewed the treatment process for prostate cancer which is caught early or slow growing. This involves frequent monitoring until the cancer becomes more aggressive. This increases the effectiveness of any treatments.
Q: whats wrong with me?
i have to pee then its really bad and sometimes i cant hold it then when i do pee there is not enough to fill a cup. i am 14 and have no clue wtf is up! please help! could it b prostate cancer or a sign of it??
its also not every time and sometimes it hurts to pee too!
A: Probably a urinary tract infection.
Are you sexually active? It could be an STD.
Go see a Dr.
Q: chances of cancer, and what to look for??
My mother had cancer, her two sisters had breast cancer, their father, my grandfather had tumors which was probably cancer, and my dad had prostate cancer?? I don't know about any one on my dads side of the family because I don't speak to them, but what do you think my chances of cancer are?? I've already asked Dr's to see if they can run some tests to check for some early signs because of my family history, all they tell me to do is call if I find a lump in my breast?! Are there any other signs I should be looking for??
A: All you can do is live a healthy life and get regular checkups. Depending on your age, you might want to get a mammogram. Most people get their first one around age 30.
Q: Need info etc on prostate operation?
Hi my dad who is 62 is going into hospital for an operation on his prostate and bladder. He is type 1 diabetic and in july he was really ill, so ill that he was.nt expected to survive. He was on life support. He had gone into heart failure, kidney failure, had fluid on his lungs. Thankfully he came out of it but when he came around and after he became better he could not urinate. So he has a catheter since july. His prostate is enlarged so i think they are removing it. His blood results for his prostate was low so they said it would be high if it was cancer so that was a good sign but could.nt rule it out yet. His own father (my grandad) died 3 months ago from prostate cancer. Anyway they are also doing surgery on his bladder. I do not know what this is for. He is keeping well since he was discharged but his blood sugars are still going very high sometimes. Up to 32mmol. Most of the time its fine but maybe every 2nd day it would go high. He has also lost some weight since being discharged from hospital. I am just worried about this opperction because of his health conditions and worried that this could set him back alot, or even is there likely to be complications because of his diabetes?
A: Firstly most enlarged prostate glands are not cancerous. Benign enlargement occurs in the vast majority of men when they get older, and this can often cause difficulty with passing water, as the prostate gland surrounds the water passage exit from the bladder. If there are only two alternatives, either living with a catheter and bag, or having surgery, then the choice is a no brainer in a man with Type 1 diabetes. Both the catheter and the diabetes will seriously predispose to recurring urine infections that can ascend to involve his already poorly kidneys.
Unfortunately because your dad has had heart failure, and other problems, the treatment of an enlarged prostate with tablets may not be possible, and so he needs surgery.
The most likey operation is called a Trans-urethral resection (TUR), and the enlarged prostate is partially removed vian an instrument inserted up the water passage (Urethra), under either general or spinal anaesthetic. This decision will depend on his general suitability and other problems, as well as his own preference if there is a choice.
These operations, carried out by a urologist are highly successful, and he will soon be without a catheter again.
Dont worry unduly about his diabetes. This is clearly an issue, but all hospitals are very well versed in controlling things during operations as Type 1 is common, and he will almost certainly have an iv with insulin and a dextrose iv as well. It is likely his blood sugars will be better controlled during his stay than at home as they will have close attention.
I hope this explanation helps. I'm sure all will be well, and it is a big thing that your dad doesn't have a catheter much longer.
Q: Blood in semen because of aggresive masturbation?
Today I found blood in my semen. I believe this is because I masturbated too aggresively. I had some boxer briefs that I "wrapped" around my penis, covering the top, sort of "suffocating" it, creating friction with the boxers and penis I thrusted up and down.
Well after I finished I noticed blood as well as semen. Additionally the tip of my penis was red with pain for hours afterward, seemingly whenever the tip of my penis touched something else it hurt. Additionally it "stinged" when I peed afterwards.
It's my belief that the blood came in result from me being waaay too aggresive in masturbating and the friction from my boxers, rather than some sign of a cancer or prostate issue.
What do you think?
Additionally, do you think this is something I should worry about??
A: It is definitely due to your aggressive behavior. I'm pretty sure your penis received the message loud and clear, your the boss! Perhaps you should try some lubricant and ease up on your friend.
Q: I feel like the biggest jerk in the world, What should I do?
Man I feel like a giant a**hole. I've always hated posers and tools, and everything but in class I was working with two seniors (kind of friends), and they saw a sign about colon cancer and asked me if I had it (jokingly), but I didn't want to be quiet or awkward, and I didn't want older kids to think I'm annoying or anything, but I said "no I have prostate cancer" only after I said this did I realize this was a horrible thing to say. I feel like I spat in the faces of families or people who died or survived prostate cancer, and that I should be repeatedly with a baseball bat or a crowbar or both. After I said this I realized I could've said a disease that isn't deadly or offensive. And most of all, at the sake of making someone laugh, and trying to set up an image of myself in someone elses eyes, I became a tool, I beacme one of people whom I despised so much, and I need to feel better or something but I feel like such a d**k
A: there's not much you can do.
you could tell the people you were talking to that you were just kidding.
but there is no need for a public apology.
the fact that you feel remorse is more that enough.
and no, it wasn't a very nice thing to say. but you said it.
you cannot go back and change it.
so don't dwell on it.
just keep going.
it's okay, dude(:
:)...melanie
Q: my dad is not healthy??
hes 54 or 55 i cant remember, but he is overweight and he has a bald head and there is a blue sort of mole on top which i do think could be a sign of skin cancer...but the thing is, that he NEVER goes the doc and he NEVER listens to advice when people tell him to take care of himself and to eat healthy and to go to the doc. he wont listen to me or my bro weve tried. what can i do???
PLEASE HELP!!
and im asking this question because my friends dad was just told he has prostate cancer and it just worries me that my dad may be worse off
A: Well its hard to get your dad to listen Im sure. Does he not have insurance? Sometimes people just dont want to know all the health problems that they fear are already happening. You could use the thing that I always said to my dad... "dont you want to live to see your grand children" " Dont you want to live to see how I grow up."
On a natural health note... get a flat cotton pad and soak it in Braggs apple cider vinegar (the only kind for this, buy at health food store) and squeeze out until its just wet enough then attach it to your dads head with some medical tape or a band aid. Have him sleep with it on the mole for 2-5 nights. It will amaze you to see what happens to the mole. It will go away. I hope you give it a try. It only costs about 2.99 for a bottle of the vinegar.
http://www.phpure.com/nutrition_products/angstrom_minerals.htm